Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis

Clinical trial NCT06726096 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06726096
Sponsor: Beijing VDJBio Co., LTD.
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)Anti IL-6R

Start date: 2025-04-09
Primary completion: 2026-04-20
Enrollment: 615

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.